文献速递遗传性与小管间质肾病

灵芝三萜通过下调Ras/MAPK信号并促进细胞分化延缓肾囊肿发展

Ganoderma triterpenes retard renal cyst development by downregulating Ras/MAPK signaling and promoting cell differentiation.
PubMed 文献 · Kidney Int · 2017-07-12

本研究探讨灵芝三萜(GT)对常染色体显性多囊肾病(ADPKD)肾囊肿发展的作用。GT在两种ADPKD小鼠模型中减轻囊肿发展,并促进MDCK细胞上皮管形成,提示促进上皮细胞分化。GT在体内外特异性下调Ras/MAPK通路激活而不影响mTOR通路,可能通过降低细胞内cAMP水平实现;筛选15种单体发现CBLZ-7(乙基灵芝酸C2)体外强效抑制囊肿发展并下调forskolin诱导的Ras/MAPK激活。

要点

  • GT在两种ADPKD小鼠模型中减轻囊肿发展。
  • GT特异性下调Ras/MAPK通路而不影响mTOR通路。
  • 单体CBLZ-7体外强效抑制囊肿发展并下调Ras/MAPK激活。

核心结论

  • 灵芝三萜及其纯化单体CBLZ-7可能成为治疗ADPKD的潜在治疗药物。

研究设计与样本

  • 研究在两种ADPKD小鼠模型及MDCK细胞中评估灵芝三萜对肾囊肿发展的作用。
  • 从灵芝三萜中纯化15种单体并筛选其对囊肿发展的影响。

主要发现

  • 灵芝三萜在两种ADPKD小鼠模型中减轻囊肿发展。
  • 灵芝三萜促进MDCK细胞上皮管形成,提示促进上皮细胞分化。
  • 灵芝三萜在体内外特异性下调Ras/MAPK通路激活,对mTOR通路无 detectable 影响。
  • 灵芝三萜下调细胞内cAMP水平可能参与上述机制。
  • CBLZ-7(乙基灵芝酸C2)体外强效抑制囊肿发展,并下调forskolin诱导的Ras/MAPK通路激活。

临床怎么用

  • 灵芝三萜及CBLZ-7可能作为ADPKD的潜在治疗药物,尚需进一步临床研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Autosomal dominant polycystic kidney disease (ADPKD) is a common monogenetic disease characterized by the progressive development of renal cysts with further need for effective therapy. Here our aim was to investigate the effect of Ganoderma triterpenes (GT) on the development of kidney cysts. Importantly, GT attenuated cyst development in two mouse models of ADPKD with phenotypes of severe cystic kidney disease. Assays for tubulogenesis showed that GT promoted epithelial tubule formation in MDCK cells, suggesting a possible effect on epithelial cell differentiation. The role of GT in regulating key signaling pathways involved in the pathogenesis of PKD was further investigated by immune blotting. This showed that GT specifically downregulated the activation of the Ras/MAPK signaling pathway both in vitro and in vivo without detectable effect on the mTOR pathway. This mechanism may be involved in GT downregulating intracellular cAMP levels. Screening of 15 monomers purified from GT for their effects on cyst development indicated that CBLZ-7 (ethyl ganoderate C2) had a potent inhibitory effect on cyst development in vitro. Additionally, like GT, CBLZ-7 was able to downregulate forskolin-induced activation of the Ras/MAPK pathway. Thus, GT and its purified monomer CBLZ-7 may be potential therapeutic regents for treating ADPKD.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Su L, Liu L, Jia Y, et al. Ganoderma triterpenes retard renal cyst development by downregulating Ras/MAPK signaling and promoting cell differentiation. Kidney Int. 2017. PMID: 28709639. doi:10.1016/j.kint.2017.04.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。